» Articles » PMID: 15735075

The Nutritional Status of Astronauts is Altered After Long-term Space Flight Aboard the International Space Station

Overview
Journal J Nutr
Publisher Elsevier
Date 2005 Mar 1
PMID 15735075
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

Defining optimal nutrient requirements is critical for ensuring crew health during long-duration space exploration missions. Data pertaining to such nutrient requirements are extremely limited. The primary goal of this study was to better understand nutritional changes that occur during long-duration space flight. We examined body composition, bone metabolism, hematology, general blood chemistry, and blood levels of selected vitamins and minerals in 11 astronauts before and after long-duration (128-195 d) space flight aboard the International Space Station. Dietary intake and limited biochemical measures were assessed during flight. Crew members consumed a mean of 80% of their recommended energy intake, and on landing day their body weight was less (P = 0.051) than before flight. Hematocrit, serum iron, ferritin saturation, and transferrin were decreased and serum ferritin was increased after flight (P < 0.05). The finding that other acute-phase proteins were unchanged after flight suggests that the changes in iron metabolism are not likely to be solely a result of an inflammatory response. Urinary 8-hydroxy-2'-deoxyguanosine concentration was greater and RBC superoxide dismutase was less after flight (P < 0.05), indicating increased oxidative damage. Despite vitamin D supplement use during flight, serum 25-hydroxycholecalciferol was decreased after flight (P < 0.01). Bone resorption was increased after flight, as indicated by several markers. Bone formation, assessed by several markers, did not consistently rise 1 d after landing. These data provide evidence that bone loss, compromised vitamin D status, and oxidative damage are among critical nutritional concerns for long-duration space travelers.

Citing Articles

Hepatotoxicity in spaceflight: intrinsic and extrinsic risks for astronaut metabolic health.

Waisberg E, Ong J, Masalkhi M, Cools B, Lee R, Vinken M Ir J Med Sci. 2025; .

PMID: 39899255 DOI: 10.1007/s11845-025-03884-w.


Tracking of spaceflight-induced bone remodeling reveals a limited time frame for recovery of resorption sites in humans.

Walle M, Gabel L, Whittier D, Liphardt A, Hulme P, Heer M Sci Adv. 2024; 10(51):eadq3632.

PMID: 39705358 PMC: 11661419. DOI: 10.1126/sciadv.adq3632.


To boldly go where no microRNAs have gone before: spaceflight impact on risk for small-for-gestational-age infants.

Corti G, Kim J, Enguita F, Guarnieri J, Grossman L, Costes S Commun Biol. 2024; 7(1):1268.

PMID: 39369042 PMC: 11455966. DOI: 10.1038/s42003-024-06944-6.


The Case for Bisphosphonate Use in Astronauts Flying Long-Duration Missions.

Rosenthal R, Schneider V, Jones J, Sibonga J Cells. 2024; 13(16.

PMID: 39195227 PMC: 11352369. DOI: 10.3390/cells13161337.


The human microbiome in space: parallels between Earth-based dysbiosis, implications for long-duration spaceflight, and possible mitigation strategies.

Etlin S, Rose J, Bielski L, Walter C, Kleinman A, Mason C Clin Microbiol Rev. 2024; 37(3):e0016322.

PMID: 39136453 PMC: 11391694. DOI: 10.1128/cmr.00163-22.